Hashimoto Isaya, Nagata Takuya, Sekine Shinichi, Moriyama Makoto, Shibuya Kazuto, Hojo Shozo, Matsui Koshi, Yoshioka Isaku, Okumura Tomoyuki, Hori Takashi, Shimada Yutaka, Tsukada Kazuhiro
Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama 930-0194, Japan.
Department of Pathology, Graduate School of Research into Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan.
Oncol Lett. 2017 Feb;13(2):819-826. doi: 10.3892/ol.2016.5499. Epub 2016 Dec 14.
To understand the roles of pluripotent stem cell-inducing genes in gastric cancer, the expression of Krüppel-like factor 4 (KLF4), Nanog, octamer-binding transcription factor 4 (Oct4), avian myelocytomatosis viral oncogene homolog (c-Myc) and sex-determining region Y-box 2 (SOX2) was examined using the newly developed gastric carcinoma tissue microarray. The associations between the immunohistochemical expression levels of the pluripotency-inducing factors and the clinicopathological data of 108 patients with gastric cancer were analyzed. No associations were identified between the expression levels of the five pluripotency-inducing factors and the tumor-node-metastasis (TNM) classification or clinicopathological characteristics of the patients. In addition, multivariate analysis revealed no association of Nanog, Oct4, SOX2 or c-Myc with the prognosis of the gastric cancer patients; however, low expression of KLF4 was determined to be an independent negative prognostic factor (P=0.0331), particularly in patients who underwent R0 resection (TNM stages 2 and 3; P=0.0048). In summary, low KLF4 expression was found to be negatively associated with overall survival, and may therefore be a useful prognostic marker in gastric cancer patients.
为了解多能干细胞诱导基因在胃癌中的作用,我们使用新开发的胃癌组织芯片检测了Krüppel样因子4(KLF4)、Nanog、八聚体结合转录因子4(Oct4)、禽成髓细胞瘤病毒癌基因同源物(c-Myc)和性别决定区Y盒2(SOX2)的表达。分析了108例胃癌患者多能性诱导因子的免疫组化表达水平与临床病理数据之间的关联。未发现五种多能性诱导因子的表达水平与患者的肿瘤-淋巴结-转移(TNM)分期或临床病理特征之间存在关联。此外,多因素分析显示Nanog、Oct4、SOX2或c-Myc与胃癌患者的预后无关;然而,KLF4低表达被确定为独立的不良预后因素(P=0.0331),尤其是在接受R0切除的患者中(TNM分期2和3;P=0.0048)。总之,发现KLF4低表达与总生存期呈负相关,因此可能是胃癌患者有用的预后标志物。